Breaking News

Charles River Joins Exostar’s Life Sciences Community

By Kristin Brooks | February 28, 2014

Aims to facilitate collaborations, reduce costs, and accelerate R&D

Charles River Laboratories has joined Exostar’s Life Sciences Identity Hub, a community of more than 500 organizations that brings CROs, pharmaceutical manufacturers, and academic institutions together to help facilitate collaborations, reduce capital and operating expenditures, and enhance productivity in speeding time-to-market.
 
Through its Secure Access Manager (SAM) service offering, organizations connect to the cloud-based Exostar Life Sciences Identity Hub, opening the door to external partner collaboration through portals, applications, and information sharing. SAM verifies identities of individuals and permits access based on authentication methods and permissions defined by asset owners.
 
“Charles River’s commitment to being a fully integrated partner with its customers makes our Life Sciences collaboration platform a perfect complement to its mission,” said Vijay Takanti, Exostar’s vice president of Security and Collaboration Solutions. “Other CROs and industry partners are enhancing their value by following Charles River’s lead and becoming part of our community.”

blog comments powered by Disqus
  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016

  • Getting Real

    Michael Pollock, PPD||November 17, 2015
    Partnering for clinical and real-world evidence studies